20,000,000 CREDIT FACILITY SECOND AMENDED AND RESTATED CREDIT AGREEMENT Dated as of September 26, 2014 by and among CRYOLIFE, INC. and each of its Subsidiaries signatory hereto, as the Borrowers, THE OTHER PERSONS PARTY HERETO THAT ARE DESIGNATED AS...Credit Agreement • October 28th, 2014 • Cryolife Inc • Surgical & medical instruments & apparatus • New York
This SECOND AMENDED AND RESTATED CREDIT AGREEMENT (including all exhibits and schedules hereto, as the same may be amended, modified and/or restated from time to time, this “Agreement”), dated as of September 26, 2014, by and among CryoLife, Inc., a Florida corporation (“CryoLife”), Cardiogenesis Corporation, a Florida corporation (“Cardiogenesis”), AuraZyme Pharmaceuticals, Inc., a Florida corporation (“AuraZyme”), Hemosphere, Inc., a Delaware corporation (“Hemosphere”), CryoLife International, Inc., a Florida corporation (“International”, and together with CryoLife, Cardiogenesis, AuraZyme and Hemosphere, the “Borrowers”, and each individually a “Borrower”), CryoLife, as Borrower Representative, the other Persons party hereto that are designated as a “Credit Party”, General Electric Capital Corporation, a Delaware corporation (in its individual capacity, “GE Capital”), as Agent for the several financial institutions from time to time party to this Agreement (collectively, the “Lender
FIRST AMENDMENT TO DISTRIBUTION AGREEMENTDistribution Agreement • October 28th, 2014 • Cryolife Inc • Surgical & medical instruments & apparatus
This FIRST AMENDMENT TO DISTRIBUTION AGREEMENT (this “First Amendment”) is entered into as of May 18, 2011, by and between (i) STARCH MEDICAL, INC., a Delaware corporation having a principal place of business at 2150 Ringwood Avenue, San Jose, California 95131 (“SMI”), (ii) CRYOLIFE, INC., a Florida corporation, having a principal place of business at 1655 Roberts Blvd. NW, Kennesaw, Georgia 30144 (“CryoLife”) and (iii) CLOTPLUS LIMITED, a limited company of Ireland having a principal place of business at Regus House, Block 4, Harcourt Road, Dublin2, Ireland (“CPL”). This First Amendment amends that certain Distribution Agreement dated September 28, 2010 between SMI and CryoLife (the “Agreement”) and adds CPL as a party for the limited purposes set forth in this First Amendment. When used herein, the term Amended Agreement refers to the Agreement as amended by this First Amendment. To the extent any provision of this First Amendment conflicts with a term of the Agreement, the provision
CRYOLIFE RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • October 28th, 2014 • Cryolife Inc • Surgical & medical instruments & apparatus
CRYOLIFE, INC. (“CryoLife”) is pleased to grant you the restricted stock award described below (“Stock Award”). This grant is made subject to the further terms and conditions set forth in this Agreement and the terms of the CryoLife, Inc. Second Amended and Restated 2009 Stock Incentive Plan (the “Plan”).
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • October 28th, 2014 • Cryolife Inc • Surgical & medical instruments & apparatus • Georgia
In consideration of the promises and mutual undertakings contained herein, and other good and valuable consideration, the receipt and sufficiency of which the parties hereby acknowledge, the parties to this Separation and Release Agreement (the “Agreement”), Jeffrey W. Burris (“Burris”) and CryoLife, Inc. (“CryoLife” or the “Company”), hereby agree as follows:
CryoLife, Inc. Kennesaw, Georgia 30144Cryolife Inc • October 28th, 2014 • Surgical & medical instruments & apparatus • Georgia
This letter sets forth the agreement (the “Agreement”) between you (the “Employee”) and CryoLife, Inc., a Florida corporation (the “Company”), regarding your option to acquire shares of the Company’s Common Stock.
